Literature DB >> 1259596

Efficacy and immune response to rubella subunits vaccines.

R Cappel, F De Cuyper.   

Abstract

Antibody and cell-mediated immunity (CMI) was measured in rabbits immunized with wild or attenuated virus and in rabbits vaccinated with a rubella subunit vaccine containing the viral envelope or nucleocapsid. The data presented show that a subunit vaccine containing the envelope proteins could induce a good antibody and CMI response. The results also suggest that such a vaccine was highly effective since 60 per cent of the rabbits immunized with the envelope proteins were protected when challenged with wild virus. This protection rate was identical as the protection achieved with a live attenuated vaccine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1259596     DOI: 10.1007/BF01320574

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  16 in total

1.  Cell mediated immunity in experimental rubella infections.

Authors:  R Cappel
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

2.  Fetal consequences of maternal rubella immunization.

Authors:  W F Fleet; E W Benz; D T Karzon; L B Lefkowitz; K L Herrmann
Journal:  JAMA       Date:  1974-02-11       Impact factor: 56.272

3.  Lymphoblast proliferation and humoral antibody response after rubella vaccination.

Authors:  M Lalla; T Vesikari; M Virolainen
Journal:  Clin Exp Immunol       Date:  1973-10       Impact factor: 4.330

4.  Large-scale purification of rubella virus and preparation of an experimental split rubella virus vaccine.

Authors:  P Väänänen; A Vaheri
Journal:  Appl Microbiol       Date:  1971-09

5.  Precipitin responses to rubella vaccine RA 27-3.

Authors:  G L Le Bouvier; S A Plotkin
Journal:  J Infect Dis       Date:  1971-02       Impact factor: 5.226

6.  Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic.

Authors:  D M Horstmann; H Liebhaber; G L Le Bouvier; D A Rosenberg; S B Halstead
Journal:  N Engl J Med       Date:  1970-10-08       Impact factor: 91.245

7.  A micro tissue culture test for the titration and neutralization of rubella virus.

Authors:  J Furesz; P Moreau; W Yarosh
Journal:  Can J Microbiol       Date:  1969-01       Impact factor: 2.419

8.  Measurement of rubella antibody by hemagglutination inhibition. II. Characteristics of an improved HAI test employing a new method for the removal of non-immunoglobulin HA inhibitors from serum.

Authors:  H Liebhaber
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

9.  Impaired cellular immunity to rubella virus in congenital rubella.

Authors:  D A Fuccillo; R W Steele; S A Hensen; M M Vincent; J B Hardy; J A Bellanti
Journal:  Infect Immun       Date:  1974-01       Impact factor: 3.441

10.  Characterization of a human acute phase protein found in association with rubella virus infection.

Authors:  R Cappel; A Schluederberg; R H Gifford; D M Horstmann
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

View more
  7 in total

1.  Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C.

Authors:  H H Chaye; C A Mauracher; A J Tingle; S Gillam
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

2.  Rubella virus antigens: localization of epitopes involved in hemagglutination and neutralization by using monoclonal antibodies.

Authors:  K Y Green; P H Dorsett
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

3.  Comparison of the humoral and cellular immune response after immunization with live, UV inactivated herpes simplex virus and a subunit vaccine and efficacy of these immunizations.

Authors:  R Cappel
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

4.  Isolation and studies of myxovirus glycoproteins.

Authors:  V A Berezin; V M Zaides; A F Artamonov; E S Isaeva; V M Zhdanov
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

5.  A bio-engineered rubella E1 antigen.

Authors:  G M Terry; L Ho-Terry; P Londesborough; K R Rees
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

6.  Characterisation of rubella virus hemagglutinin rosettes.

Authors:  M Trudel; F Marchessault; P Payment
Journal:  J Virol Methods       Date:  1981-03       Impact factor: 2.014

7.  Immunogenic properties of SARS-CoV-2 inactivated by ultraviolet light.

Authors:  A V Gracheva; E R Korchevaya; Yu I Ammour; D I Smirnova; O S Sokolova; G S Glukhov; A V Moiseenko; I V Zubarev; R V Samoilikov; I A Leneva; O A Svitich; V V Zverev; Evgeny B Faizuloev
Journal:  Arch Virol       Date:  2022-07-20       Impact factor: 2.685

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.